Inventor · disambiguated record
Anne Fortier
Also filed as: FORTIER ANNE · FORTIER ANNE H
6 granted patents·4 pending applications·91 citations·filing 1999–2024
82Inventor score
Top patents by PatentIndex Score
10 records- 0193US6544947B2Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using cancer markersENTREMED INC·Filed 2001·Granted Apr 8, 2003·54 cites·13 claims
- 0291US12060346B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Aug 13, 2024·1 cites·53 claims
- 0391US11618746B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2019·Granted Apr 4, 2023·6 cites·28 claims
- 0482US12281102B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Apr 22, 2025·1 cites·38 claims
- 0582US12116343B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Oct 15, 2024·1 cites·33 claims
- 0678US2025042878A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0768US6413513B1Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using cancer markersENTREMED INC·Filed 1999·Granted Jul 2, 2002·28 cites·6 claims
- 0853US2023014907A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 0947US2003012792A1Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using cancer markersFiled 2002·Application pending·0 cites
- 1044US2004253226A1Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteasesFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anne Fortier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →